Belsha C W, Kohaut E C, Warady B A
Department of Pediatrics, University of Arkansas for Medical Sciences, Arkansas Children's Hospital, Little Rock 72202, USA.
Pediatr Nephrol. 1995 Jun;9(3):361-3. doi: 10.1007/BF02254215.
A 35-question survey was mailed to 19 pediatric nephrologists regarding dialytic management of acute renal failure (ARF). Fifteen surveys were returned (79%). The purpose of the survey was to determine which renal replacement therapies (RRT) are most frequently used in the management of children with ARF in North America. Nephrologists were also questioned about clinical factors that influence the decisions to initiate RRT and choice of a particular modality. Survey results showed that hemofiltration was the initial choice for RRT among nephrologists (median value 40%, range 0%-100%) more often in their patients in the past 12 months than peritoneal dialysis (median value 30%, range 0%-85%) or hemodialysis (median value 20%, range 0%-50%). Factors considered most important in the decision to initiate dialysis include abnormalities in serum potassium, fluid balance, blood pressure and nutritional needs. Patient size and dialysis access were additional factors considered important in the choice of RRT modality.
一份包含35个问题的调查问卷被邮寄给了19位儿科肾病专家,内容涉及急性肾衰竭(ARF)的透析管理。共收回15份调查问卷(回收率79%)。该调查的目的是确定北美地区在治疗儿童急性肾衰竭时最常使用的肾脏替代疗法(RRT)。同时,还询问了肾病专家一些影响开始肾脏替代疗法决策以及特定治疗方式选择的临床因素。调查结果显示,在过去12个月里,血液滤过作为肾脏替代疗法的初始选择,在肾病专家的患者中比腹膜透析(中位数为30%,范围为0%-85%)或血液透析(中位数为20%,范围为0%-50%)更为常见(中位数为40%,范围为0%-100%)。在决定开始透析时被认为最重要的因素包括血清钾异常、液体平衡、血压和营养需求。患者体型和透析通路是在选择肾脏替代疗法方式时被认为重要的其他因素。